• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌国际抗癌联盟(UICC)TNM分类评估。对228例患者的研究。

Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patients.

作者信息

Balzano G, Bassi C, Zerbi A, Falconi M, Calori G, Butturini G, Leone B E, Pederzoli P, Di Carlo V

机构信息

Department of Surgery, Borgoroma Hospital, Verona, Italy.

出版信息

Int J Pancreatol. 1997 Apr;21(2):111-8. doi: 10.1007/BF02822382.

DOI:10.1007/BF02822382
PMID:9209952
Abstract

CONCLUSION

A different stage grouping of TNM factors can improve the predictivity of the UICC TNM classification for pancreatic cancer. Nevertheless, the Japanese Pancreas Society (JPS) classification maintains a higher prognostic value.

BACKGROUND

The use of a reliable staging classification facilitates the evaluation of anticancer treatments and the correct management of patients. The aim of the present study was to evaluate the prognostic value of three modified UICC TNM classifications, obtained by different stage grouping of the UICC TNM factors, comparing their predictivity to the standard UICC and the JPS classifications.

METHODS

Clinical material consisted of 228 patients who underwent resection for pancreatic cancer. The reliability of the classifications was analyzed by the following methods: univariate analysis of stage survival curves; multivariate analysis of each classification after adjusting for grading and radicality; and correlation between the patients' distribution in the stages of each classification and in survival classes.

RESULTS

The following modified UICC classification allowed a better differentiation of stage II and III survival (P = 0.08) than standard UICC (P = 0.74): stage I: T1N0M0; stage II: T1N1M0/T2N0M0: stage III: T2N1M0/T3 any NM0; stage IV: M1. The JPS classification better discriminated between the different stages (P < 0.001). All classifications had an independent prognostic value by multivariate analysis. The correlation between stages and survival classes was higher for the JPS classification than either UICC TNM classification or the modified UICC classifications.

摘要

结论

对TNM因素进行不同的分期分组可提高国际抗癌联盟(UICC)TNM分类对胰腺癌的预测性。然而,日本胰腺学会(JPS)分类仍具有更高的预后价值。

背景

使用可靠的分期分类有助于评估抗癌治疗效果及对患者进行正确管理。本研究的目的是评估通过对UICC TNM因素进行不同分期分组得到的三种改良UICC TNM分类的预后价值,并将它们的预测性与标准UICC分类及JPS分类进行比较。

方法

临床资料包括228例行胰腺癌切除术的患者。通过以下方法分析分类的可靠性:分期生存曲线的单因素分析;在调整分级和根治性后对每种分类进行多因素分析;以及每种分类的分期与生存类别中患者分布之间的相关性。

结果

以下改良UICC分类比标准UICC分类能更好地区分II期和III期的生存率(P = 0.08,标准UICC分类P = 0.74):I期:T1N0M0;II期:T1N1M0/T2N0M0;III期:T2N1M0/T3任何NM0;IV期:M1。JPS分类能更好地区分不同分期(P < 0.001)。通过多因素分析,所有分类均具有独立的预后价值。JPS分类的分期与生存类别之间的相关性高于UICC TNM分类或改良UICC分类。

相似文献

1
Evaluation of UICC TNM classification for pancreatic cancer. A study of 228 patients.胰腺癌国际抗癌联盟(UICC)TNM分类评估。对228例患者的研究。
Int J Pancreatol. 1997 Apr;21(2):111-8. doi: 10.1007/BF02822382.
2
Classification of pancreatic cancer: comparison of Japanese and UICC classifications.胰腺癌的分类:日本分类与国际抗癌联盟(UICC)分类的比较
Pancreas. 2004 Apr;28(3):231-4. doi: 10.1097/00006676-200404000-00003.
3
Stage classifications of pancreatic cancer: comparison of the Japanese and UICC classifications and proposal for a new staging system. Union Internationale Contre le Cancer.胰腺癌的分期分类:日本与国际抗癌联盟(UICC)分类的比较及新分期系统的提议。国际抗癌联盟
Pancreas. 1998 Apr;16(3):255-64.
4
Reliability of pancreatic cancer staging classifications.胰腺癌分期分类的可靠性。
Int J Pancreatol. 1994 Feb;15(1):13-8. doi: 10.1007/BF02924383.
5
[Evaluation of classification of pancreatic cancer by the Japan Pancreas Society and Union Internationale Contre le Cancer and proposal for a new international classification].[日本胰腺学会和国际抗癌联盟对胰腺癌分类的评估及新国际分类的提议]
Nihon Geka Gakkai Zasshi. 2000 Feb;101(2):205-11.
6
[Does the new UICC classification allow better prognostic assessment for ductal pancreatic carcinoma?].
Chirurg. 2000 Feb;71(2):189-95. doi: 10.1007/s001040050032.
7
pT but not pN stage of the 8th TNM classification significantly improves prognostication in pancreatic ductal adenocarcinoma.第八版TNM分期中的pT分期而非pN分期能显著改善胰腺导管腺癌的预后评估。
Eur J Cancer. 2017 Oct;84:121-129. doi: 10.1016/j.ejca.2017.06.034. Epub 2017 Aug 10.
8
Staging systems for pancreatic cancer: differences between the Japanese and UICC systems.胰腺癌分期系统:日本与国际抗癌联盟(UICC)系统的差异
J Hepatobiliary Pancreat Surg. 1998;5(2):121-7. doi: 10.1007/s005340050021.
9
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.内分泌胰腺肿瘤的 TNM 分期:来自大型国际队列研究的结果。
J Natl Cancer Inst. 2012 May 16;104(10):764-77. doi: 10.1093/jnci/djs208. Epub 2012 Apr 23.
10
[Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].[UICC-AJCC第7版食管癌和胃癌TNM分期系统对食管胃交界腺癌(SiewertⅡ型)预后预测价值的评估]
Zhonghua Zhong Liu Za Zhi. 2014 Dec 23;36(12):916-21. doi: 10.3760/cma.j.issn.0253-3766.2014.12.008.

引用本文的文献

1
Prediction of Pathologic Change Development in the Pancreas Associated with Diabetes Mellitus Assessed by NMR Metabolomics.通过 NMR 代谢组学预测与糖尿病相关的胰腺病理变化发展。
J Proteome Res. 2023 Jun 2;22(6):1936-1946. doi: 10.1021/acs.jproteome.3c00047. Epub 2023 Apr 5.
2
p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.p16INK4a是切除的导管胰腺癌的一个预后标志物:p16INK4a、p53、MDM2和Rb的分析
Ann Surg. 2002 Jan;235(1):51-9. doi: 10.1097/00000658-200201000-00007.

本文引用的文献

1
Reliability of pancreatic cancer staging classifications.胰腺癌分期分类的可靠性。
Int J Pancreatol. 1994 Feb;15(1):13-8. doi: 10.1007/BF02924383.
2
Staging of pancreatic cancer: suggestions for a simplified, reliable modification of the TNM classification system.胰腺癌分期:对TNM分类系统进行简化、可靠修订的建议。
Int J Pancreatol. 1995 Apr;17(2):213-4. doi: 10.1007/BF02788542.
3
Staging of cancer of the pancreas. Cancer of the Pancreas Task Force.
Cancer. 1981 Mar 15;47(6 Suppl):1631-9. doi: 10.1002/1097-0142(19810315)47:6+<1631::aid-cncr2820471428>3.0.co;2-3.
4
Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas.病理分期在外分泌性胰腺癌手术治疗中的重要性。
Am J Surg. 1974 Jun;127(6):653-7. doi: 10.1016/0002-9610(74)90341-9.
5
Multivariate survival analysis using Cox's regression model.使用Cox回归模型进行多变量生存分析。
Hepatology. 1987 Nov-Dec;7(6):1346-58. doi: 10.1002/hep.1840070628.
6
Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases.
Histopathology. 1985 Aug;9(8):841-56. doi: 10.1111/j.1365-2559.1985.tb02870.x.
7
UICC and Japanese stage classifications for carcinoma of the pancreas.国际抗癌联盟(UICC)和日本的胰腺癌分期分类
Int J Pancreatol. 1991 Apr;8(3):205-14. doi: 10.1007/BF02924539.
8
[New aspects of pancreatic carcinoma (author's transl)].
Dtsch Med Wochenschr. 1979 Dec 21;104(51):1801-5. doi: 10.1055/s-0028-1129194.